StockWatch
·
Pharmaceuticals
Quarterly Result25 Jul 2026, 12:30 pm

Mercury Laboratories declares unaudited Q1 FY27 results

AI Summary

Mercury Laboratories Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on July 25, 2026. The company also provided the Limited Review Report from its statutory auditors. The financial results are prepared in accordance with Indian Accounting Standards and SEBI (LODR) Regulations, 2015. The company operates in a single segment, "Pharmaceuticals Products".

Key Highlights

  • Unaudited financial results for Q1 FY27 declared.
  • Board of Directors approved results on July 25, 2026.
  • Limited Review Report by Statutory Auditors attached.
  • Company operates in a single segment: Pharmaceuticals Products.